Podcast by CEO, Norges Bank Investment Management, In Good Company with Nicolai Tangen

In Good Company with Nicolai Tangen

Podcast by CEO, Norges Bank Investment Management

The CEO of the largest single investor in the world, Norges Bank Investment Management, interviews leaders of some of the largest companies in the world. You will get to know the leader, their strategy, leadership principles, and much more. Hosted on Acast. See https://www.acast.com/privacy-policy for more information.

Equity Bottom-Up

<ul><li>Nicola Tangent and Thomas Schnecker discuss the success and innovation of Roche, a leading healthcare company.</li><li>Schnecker highlights the importance of understanding the genome to drive innovation in cancer treatment.</li><li>The conversation delves into the impact of pricing, leadership, and the company's long-term vision and commitment to patient outcomes.</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.</em></p>

Nicola Tangent and Thomas Schnecker discuss the success and innovation of Roche, a leading healthcare company.Schnecker highlights the importance of understanding the genome to drive innovation in cancer treatment.The conversation delves into the impact of pricing, leadership, and the company's long-term vision and commitment to patient outcomes.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

United States

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Roche Holding (ROG SW)

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

The CEO of Roche, a leading healthcare company, discusses their role in driving innovation and advancements in cancer treatment, personalized...

In Good Company with Nicolai Tangen

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)